These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2173560)

  • 1. Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli.
    Forsberg G; Palm G; Ekebacke A; Josephson S; Hartmanis M
    Biochem J; 1990 Oct; 271(2):357-63. PubMed ID: 2173560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor I.
    Canova-Davis E; Eng M; Mukku V; Reifsnyder DH; Olson CV; Ling VT
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):207-13. PubMed ID: 1637301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of recombinant human insulin-like growth factor II (IGF-II) expressed as a secreted fusion protein in Escherichia coli.
    Wadensten H; Ekebacke A; Hammarberg B; Holmgren E; Kalderén C; Tally M; Moks T; Uhlén M; Josephson S; Hartmanis M
    Biotechnol Appl Biochem; 1991 Jun; 13(3):412-21. PubMed ID: 1883532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two chemical cleavage methods for preparation of a truncated form of recombinant human insulin-like growth factor I from a secreted fusion protein.
    Forsberg G; Baastrup B; Brobjer M; Lake M; Jörnvall H; Hartmanis M
    Biofactors; 1989 Dec; 2(2):105-12. PubMed ID: 2696476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding protein, radioreceptor and biological activities of recombinant methionyl insulin-like growth factor-I variants.
    Hodgkinson SC; Napier JR; Davis SR; Patel B; Gluckman PD
    Mol Cell Endocrinol; 1989 Sep; 66(1):37-44. PubMed ID: 2479583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.
    Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR
    J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins.
    King R; Wells JR; Krieg P; Snoswell M; Brazier J; Bagley CJ; Wallace JC; Ballard FJ; Ross M; Francis GL
    J Mol Endocrinol; 1992 Feb; 8(1):29-41. PubMed ID: 1311930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I.
    Forsberg G; Baastrup B; Rondahl H; Holmgren E; Pohl G; Hartmanis M; Lake M
    J Protein Chem; 1992 Apr; 11(2):201-11. PubMed ID: 1388667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an extended form of recombinant human insulin-like growth factor II.
    Hammarberg B; Tally M; Samuelsson E; Wadensten H; Holmgren E; Hartmanis M; Hall K; Uhlén M; Moks T
    J Biol Chem; 1991 Jun; 266(17):11058-62. PubMed ID: 1645723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
    Jansson M; Uhlen M; Nilsson B
    Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification.
    Moks T; Abrahmsén L; Holmgren E; Bilich M; Olsson A; Uhlén M; Pohl G; Sterky C; Hultberg H; Josephson S
    Biochemistry; 1987 Aug; 26(17):5239-44. PubMed ID: 3676250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of an insulin-like growth factor II variant from human plasma.
    Hampton B; Burgess WH; Marshak DR; Cullen KJ; Perdue JF
    J Biol Chem; 1989 Nov; 264(32):19155-60. PubMed ID: 2553732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression and simple purification of recombinant human insulin-like growth factor I.
    Kim SO; Lee YI
    J Biotechnol; 1996 Jul; 48(1-2):97-105. PubMed ID: 8818276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
    Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification and characterization of secreted recombinant human insulin-like growth factor-I (IGF-I) and the potent variant des(1-3) IGF-I in Chinese hamster ovary cells.
    McKinnon P; Ross M; Wells JR; Ballard FJ; Francis GL
    J Mol Endocrinol; 1991 Jun; 6(3):231-9. PubMed ID: 1883485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
    Hodgson DR; May FE; Westley BR
    Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I.
    Sara VR; Carlsson-Skwirut C; Andersson C; Hall E; Sjögren B; Holmgren A; Jörnvall H
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4904-7. PubMed ID: 3460078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of insulin-like growth factor I using N-methyl pyrrolidinone as the coupling solvent and trifluoromethane sulphonic acid cleavage from the resin.
    Bagley CJ; Otteson KM; May BL; McCurdy SN; Pierce L; Ballard FJ; Wallace JC
    Int J Pept Protein Res; 1990 Oct; 36(4):356-61. PubMed ID: 1964154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding.
    Ballard FJ; Francis GL; Ross M; Bagley CJ; May B; Wallace JC
    Biochem Biophys Res Commun; 1987 Dec; 149(2):398-404. PubMed ID: 2962574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.
    Jansen J; van Buul-Offers SC; Hoogerbrugge CM; Van Den Brande JL
    Biochem J; 1990 Mar; 266(2):513-20. PubMed ID: 2156497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.